BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Bachem AG

Below is an extended Bachem AG research listing. Click here to return to the Bachem AG main Biocorporate entry.

Recent Publications by Bachem AG:

Formation of Fmoc-beta-alanine during Fmoc-protections with Fmoc-OSu.
During the Fmoc-protection of H-alpha-Me-Val-OH, an unknown side product...
19th August, 2008
Bachem AG, Bubendorf, Switzerland. J Pept Sci. 2008 Jun;14(6):763-6.
DOI Direct Link
The aspartimide problem in Fmoc-based SPPS. Part III.
A newly developed Fmoc-Asp derivative, Fmoc-Asp...
16th November, 2005
Bachem AG, Hauptstr. 144, CH-4416 Bubendorf, Switzerland. J Pept Sci. 2005 Oct;11(10):650-7.
DOI Direct Link
The aspartimide problem in Fmoc-based SPPS. Part II.
The sequence dependence of base-catalysed aspartmide formation during...
30th March, 2004
BACHEM AG, Hauptstr. 144, CH-4416 Bubendorf, Switzerland. J Pept Sci. 2003 Aug;9(8):518-26.
DOI Direct Link
The aspartimide problem in Fmoc-based SPPS. Part I.
A variety of Asp beta-carboxy protecting groups, Hmb backbone protection...
6th August, 2003
BACHEM AG, Hauptstr. 144, CH-4416 Bubendorf, Switzerland. J Pept Sci. 2003 Jan;9(1):36-46.
DOI Direct Link
Synthesis and application of an auxiliary group for chemical ligation at the X-gly site.
An efficient synthesis of an auxiliary group, the...
13th February, 2003
BACHEM AG, Hauptstrasse 144, CH-4416 Bubendorf, Switzerland. Bioorg Med Chem Lett. 2002 Aug 5;12(15):1963-5.

«Bachem AG

This page contained an extended Bachem AG research listing. Click here to return to the Bachem AG main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.